Javascript must be enabled to continue!
Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway
View through CrossRef
IgG is a key to adaptive immunity and a critical platform for drug design. Sialic acid on the conserved glycan within the Fc domain is believed to promote anti-inflammatory IgG function; however, regulation of sialylation remains poorly defined. We previously showed that IgG sialylation is primarily mediated by B cell–extrinsic processes in mice. Here, we found that IgG sialylation occurs in the subcellular compartments of the FcRn-mediated IgG recycling pathway of endothelial cells. This process is down-regulated by inflammatory signals and up-regulated during gestation, providing mechanistic insight into the epidemiology associating IgG glycosylation, pregnancy and inflammatory disease. These findings demonstrate that plasma-localized IgG glycosylation is dynamically altered by the endothelium, revealing a potential mechanism through which the function of all endogenous and administered IgG and Fc-containing pharmaceuticals could be altered.
Title: Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway
Description:
IgG is a key to adaptive immunity and a critical platform for drug design.
Sialic acid on the conserved glycan within the Fc domain is believed to promote anti-inflammatory IgG function; however, regulation of sialylation remains poorly defined.
We previously showed that IgG sialylation is primarily mediated by B cell–extrinsic processes in mice.
Here, we found that IgG sialylation occurs in the subcellular compartments of the FcRn-mediated IgG recycling pathway of endothelial cells.
This process is down-regulated by inflammatory signals and up-regulated during gestation, providing mechanistic insight into the epidemiology associating IgG glycosylation, pregnancy and inflammatory disease.
These findings demonstrate that plasma-localized IgG glycosylation is dynamically altered by the endothelium, revealing a potential mechanism through which the function of all endogenous and administered IgG and Fc-containing pharmaceuticals could be altered.
Related Results
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential
Abstract
Background
Optimizing the IgG Fc domain for neonatal Fc receptor (FcRn) binding is crucial for enhancing antibod...
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
Quantitative real-time PCR and Western blot methods were developed to assess neonatal Fc-receptor (FcRn) mRNA and protein expression in human FcRn transgenic mice, Swiss Webster mi...
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Abstract
Molecular interactions between therapeutic antibodies and neonatal Fc receptor (FcRn) are major contributors to the long serum half-life of antibodies. T...
FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
Monoclonal antibodies (mAbs) are promising therapies to treat airway chronic inflammatory disease (asthma or nasal polyps). To date, no study has specifically assessed, in vitro, t...
Neonatal fc receptor antagonists in adult patients with primary immune thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials
Neonatal fc receptor antagonists in adult patients with primary immune thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials
Abstract
Introduction Primary immune thrombocytopenia (ITP) is an autoimmune condition marked by low platelet counts due...
Abstract 1653: FcRn humanized rats for pharmacokinetics assessment of antibody drugs
Abstract 1653: FcRn humanized rats for pharmacokinetics assessment of antibody drugs
Abstract
Introduction:
Biocytogen's B-hFcRn rat model serves as a practical tool for assessing the pharmacokinetics/pharm...
IgG sialylation occurs via the FcRn-mediated recycling pathway in endothelial cells
IgG sialylation occurs via the FcRn-mediated recycling pathway in endothelial cells
Abstract
IgG is a key mediator of immune responses throughout the human body, and the structure of the conserved glycan on the Fc region has been...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

